Get started
Author

Alexander N. Chernov

Observed names: A. Chernov, A. N. CHERNOV, A. N. Chernov, A.N. Chernov, Alexander Chernov, Alexander N Chernov, Alexandr Chernov, Alexandr N. Chernov, Chernov, Alexandr, А. Н. Чернов, А.Н. Чернов
Observed institutions: Ben-Gurion University of the Negev, National Academy of Sciences of Belarus, Federal Almazov North-West Medical Research Centre, Research Institute of Obstetrics and Gynecology named after D.O. Ott, Institute of Physiology National Academy of Sciences of Belarus, HUN-REN Institute of Experimental Medicine, City Hospital No. 40, Ministry of Health of the Russian Federation, Institute of Experimental Medicine, Saint Petersburg State Pediatric Medical University
ORCID: 0000-0003-2464-7370
Observed ORCID: 0000-0003-2464-7370
OpenAlex ID: A5044692108
Fourth Generation Phosphorus-Containing Dendrimers: Prospective Drug and Gene Delivery Carrier
2011 · D. Shcharbin, V. Dzmitruk, et al. · Pharmaceutics · 54
PDF
Biological activity of silver-doped DLC films
2009 · N.M. Chekan, N.M. Beliauski, et al. · Diamond and Related Materials · 45
Cytotoxic Effects of Chemotherapeutic Drugs and Heterocyclic Compounds at Application on the Cells of Primary Culture of Neuroepithelium Tumors
2012 · Vladimir A. Kulchitsky, Vladimir I. Potkin, et al. · Medicinal Chemistry · 44
Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome
2020 · Anton E. Shikov, Yury A. Barbitoff, et al. · Frontiers in Genetics · 41
PDF
Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients
2021 · Sergey G. Shcherbak, Anna Yu Anisenkova, et al. · Frontiers in Immunology · 38
PDF
Human Exome Sequencing and Prospects for Predictive Medicine: Analysis of International Data and Own Experience
2023 · Oleg S. Glotov, Alexander N. Chernov, et al. · Journal of Personalized Medicine · 28
PDF
The Phenomenon of Multidrug Resistance in Glioblastomas
2021 · Alexandr N. Chernov, Diana A. Alaverdian, et al. · Hematology/Oncology and Stem Cell Therapy · 27
Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells
2022 · Alexandr N. Chernov, Tatiana A. Filatenkova, et al. · Molecules · 16
PDF
Pharmacogenetic Study of the Impact of ABCB1 Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients
2022 · Alexandr Chernov, Daria Kilina, et al. · Pharmaceutics · 15
PDF
Clinical and Genetic Characteristics of Pediatric Patients with Hypophosphatasia in the Russian Population
2022 · Oleg S. Glotov, Kirill V. Savostyanov, et al. · International Journal of Molecular Sciences · 15
PDF
In Vitro Evaluation of the Cytotoxic Effect of Streptococcus pyogenes Strains, Protegrin PG-1, Cathelicidin LL-37, Nerve Growth Factor and Chemotherapy on the C6 Glioma Cell Line
2022 · Alexandr N. Chernov, Anna Tsapieva, et al. · Molecules · 14
PDF
Genetic Risk Factors for the Development of COVID-19 Coronavirus Infection
2021 · O. S. Glotov, A. N. Chernov, et al. · Russian Journal of Genetics · 14
PDF
Pathophysiological mechanisms of autism in children
2020 · A.N. Chernov · S S Korsakov Journal of Neurology and Psychiatry · 13
Identification of Genetic Risk Factors of Severe COVID-19 Using Extensive Phenotypic Data: A Proof-of-Concept Study in a Cohort of Russian Patients
2022 · Sergey G. Shcherbak, Anton I. Changalidi, et al. · Genes · 10
PDF
Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells
2024 · Alexandr N. Chernov, Alexandr V. Kim, et al. · Cancer Chemotherapy and Pharmacology · 9
Polymorphisms in corticotrophin‐releasing hormone–proopiomalanocortin ( CRH – POMC ) system genes: Neuroimmune contributions to psoriasis disease
2023 · Elvira Galimova, Ranno Rätsep, et al. · Journal of the European Academy of Dermatology and Venereology · 9
PDF
Biomimetic Cu2−xSe nanoplatforms for efficient glioblastoma treatment: overcoming the blood-brain barrier and boosting Immunogenetic cell death
2025 · Sijia Lin, Haiyan Xing, et al. · Journal of Nanobiotechnology · 8
PDF
Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections
2023 · Stanislav Urazov, Alexandr Chernov, et al. · International Journal of Molecular Sciences · 8
PDF
Nerve Growth Factor, Antimicrobial Peptides and Chemotherapy: Glioblastoma Combination Therapy to Improve Their Efficacy
2023 · Alexandr Chernov, Igor Kudryavtsev, et al. · Biomedicines · 7
PDF
Studying the Oncolytic Activity of Streptococcus pyogenes Strains Against Hepatoma, Glioma, and Pancreatic Cancer In Vitro and In Vivo
2025 · Anna N. Tsapieva, Alexander N. Chernov, et al. · Microorganisms · 6
PDF
Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients
2024 · Alexander N Chernov, Sofia S Skliar, et al. · Pharmaceutics · 6
PDF
Exome Sequencing for the Diagnostics of Osteogenesis Imperfecta in Six Russian Patients
2024 · Yulia S. Koshevaya, Mariia E. Turkunova, et al. · Current Issues in Molecular Biology · 3
Secretory phospholipase A2: a biomarker of inflammation in autoimmune, bacterial and viral diseases
2022 · S. P. Urazov, A. N. Chernov, et al. · Medical Immunology (Russia) · 3
PDF
The methods of in vitro selection of chemotherapeutic druds for individual chemotherapy of maligant tumors in patinets
2018 · A. N. Chernov, E. P. Barantsevich, et al. · Translational Medicine · 3
PDF
Glioblastoma and Blood Microenvironment Predictive Model for Life Expectancy of Patients
2025 · Alexander N. Chernov, Sofia S. Skliar, et al. · Biomedicines · 2
PDF
Works count: 56
Citation count: 454
H-index: 13
I10-index: 14
Year
Topic
Type